Nikke Chemical announced that the closing price increase deviation value of the company's stock exceeded 30% for two consecutive trading days on July 13 and July 14, 2026, which is an abnormal fluctuation in stock trading. After verification, the company held a board meeting on July 10, 2026 to deliberate and pass proposals relating to issuing shares and paying cash to purchase assets and raise supporting capital and related transactions. Currently, the specific transaction plan is still being further negotiated and refined, and related audits and evaluations have not yet been completed. The final transaction plan is based on the restructuring report disclosed later, and there is still great uncertainty about this transaction.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.